Alzheimer's disease biomarker‐guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ 1–42 , total‐tau, phosphorylated‐tau, NFL, neurogranin, and YKL‐40-Reference-Cited by-同舟云学术

Alzheimer's disease biomarker‐guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ 1–42 , total‐tau, phosphorylated‐tau, NFL, neurogranin, and YKL‐40

Published:2018-01-09 Issue:4 Volume:14 Page:492-501
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Hampel Harald¹²³⁴,Toschi Nicola⁵⁶⁷,Baldacci Filippo¹²³⁴⁸,Zetterberg Henrik⁹¹⁰¹¹¹²,Blennow Kaj⁹¹⁰,Kilimann Ingo¹³,Teipel Stefan J.¹³,Cavedo Enrica¹²³⁴¹⁴,Melo dos Santos Antonio²³⁴,Epelbaum Stéphane²³⁴,Lamari Foudil¹⁵,Genthon Remy²³⁴,Dubois Bruno²³⁴,Floris Roberto⁵,Garaci Francesco⁵¹⁶,Lista Simone¹²³⁴,

Affiliation:

1. AXA Research Fund & Sorbonne Université Chair Paris France

2. Sorbonne Université, AP‐HP, GRC n° 21 Alzheimer Precision Medicine (APM), Hôpital de la Pitié‐Salpêtrière Paris France

3. Institut du Cerveau et de la Moelle Épinière (ICM) INSERM U 1127, CNRS UMR 7225 Paris France

4. Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) Département de Neurologie, Hôpital de la Pitié‐Salpêtrière Paris France

5. Department of Biomedicine and Prevention University of Rome “Tor Vergata” Rome Italy

6. Department of Radiology “Athinoula A. Martinos” Center for Biomedical Imaging Boston MA USA

7. Harvard Medical School Boston MA USA

8. Department of Clinical and Experimental Medicine University of Pisa Pisa Italy

9. Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry The Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden

10. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden

11. Department of Molecular Neuroscience UCL Institute of Neurology Queen Square London UK

12. UK Dementia Research Institute London UK

13. Department of Psychosomatic Medicine University of Rostock & DZNE Rostock Rostock Germany

14. IRCCS Centro San Giovanni di Dio Fatebenefratelli Brescia Italy

15. AP‐HP, UF Biochimie des Maladies Neuro‐métaboliques, Service de Biochimie Métabolique Groupe Hospitalier Pitié‐Salpêtrière Paris France

16. Casa di Cura “San Raffaele Cassino” Cassino Italy

Funder

Pfizer

AXA Research Fund

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2017.11.015

Reference54 articles.

1. Alzheimer's disease

2. Presence of parieto-temporal symptomatology distinguishes early and late onset Alzheimer's disease

3. Confusional symptomatology distinguishes early‐ and late‐onset Alzheimer's disease;Blennow K;Aging Milan Italy,1990

4. Imaging epigenetics in Alzheimer's disease;Lista S;Curr Pharm Des,2013

5. Alzheimer's disease

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-519a-3p, found to regulate cellular prion protein during Alzheimer’s disease pathogenesis, as a biomarker of asymptomatic stages;2023-12-15

2. Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer’s Disease or Other Neurological Diseases;Journal of Alzheimer's Disease;2023-12-06

3. The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease;Brain;2023-08-04

4. The risk of dementia or cognitive impairment in patients with cataracts: a systematic review and meta-analysis;Aging & Mental Health;2023-07-07

5. Altered MANF and RYR2 concentrations associated with hypolipidemia in the serum of patients with schizophrenia;Journal of Psychiatric Research;2023-07